0001213900-13-003266.txt : 20130624
0001213900-13-003266.hdr.sgml : 20130624
20130624192001
ACCESSION NUMBER: 0001213900-13-003266
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130620
FILED AS OF DATE: 20130624
DATE AS OF CHANGE: 20130624
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SOLIGENIX, INC.
CENTRAL INDEX KEY: 0000812796
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 411505029
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE C-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-538-8200
MAIL ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE C-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: DOR BIOPHARMA INC
DATE OF NAME CHANGE: 20020329
FORMER COMPANY:
FORMER CONFORMED NAME: ENDOREX CORP
DATE OF NAME CHANGE: 19960916
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ZELDIS JEROME B
CENTRAL INDEX KEY: 0001433982
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-16929
FILM NUMBER: 13930601
MAIL ADDRESS:
STREET 1: 8767 E. VIA DE VENTURA, SUITE 190
CITY: SCOTTSDALE
STATE: AZ
ZIP: 85258
4
1
f4062013zeldis_soligenix.xml
X0306
4
2013-06-20
0
0000812796
SOLIGENIX, INC.
SNGX
0001433982
ZELDIS JEROME B
29 EMMONS DRIVE, SUITE C-10
PRINCETON
NJ
08540
1
0
0
0
Common Stock
2013-06-20
4
M
0
25000
0.30
A
25000
D
Stock Option (Right to Buy)
0.30
2013-06-20
4
M
0
25000
0
D
2022-06-20
Common Stock
25000
0
D
The option vested in installments of 6,250 shares on each of September 21, 2012, December 21, 2012, March 21, 2012 and June 21, 2012.
/s/ Jerome B. Zeldis
2013-06-24